Fluzone is a brand of seasonal influenza vaccine developed and manufactured by Sanofi Pasteur, one of the world's leading pharmaceutical companies. The Fluzone vaccine is designed to protect individu...
Fluzone High-Dose Quadrivalent is a seasonal influenza vaccine that is specially formulated to contain four times the antigen as standard dose flu vaccines. This vaccine is manufactured by Sanofi Pasteur Inc. and is the only licensed high-dose inactivated influenza vaccine available on the market. It is approved for use in adults aged 65 years and older.
The high-dose formulation is designed to create a stronger immune response after vaccination compared to standard dose vaccines. This increased immune response is important for older adults, as they are at a higher risk for severe illness and complications from influenza.
Several studies have shown that Fluzone High-Dose Quadrivalent is safe and effective in preventing seasonal influenza in older adults. The vaccine has also been shown to be well-tolerated, with similar side effects to standard dose vaccines.
In addition to Fluzone High-Dose Quadrivalent, there are other recommended flu vaccines for older adults , including Flublok Quadrivalent recombinant flu vaccine and Fluad Quadrivalent. It is important to talk to your healthcare provider about which vaccine is best for you.
Overall, Fluzone High-Dose Quadrivalent is an important option for older adults in protecting against seasonal influenza and reducing the risk of severe illness and complications.